ArticleBreast cancer research : BCR2016

SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.

Fatimah Matalkah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.